KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / American Depositary Shares, each representing five-hundred Ordinary Shares
Symbol
KZIA on Nasdaq
Shares outstanding
11,387,333
Price per share
$6.10
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,479,478
Total reported value
$17,070,899
% of total 13F portfolios
0%
Share change
+2,151,403
Value change
+$14,797,378
Number of holders
22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynwood Capital Management Inc. 5.4% $2,107,941,734 307,998,500 Lynwood Capital Management Inc. 15 Jan 2026
Ikarian Capital, LLC 5.1% $3,740,056 580,754 Ikarian Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 22 institutional investors reported holding 2,479,478 shares of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA). This represents 22% of the company’s total 11,387,333 outstanding shares.

Top 23 Institutional Shareholders

The largest institutional shareholders of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) together control 22% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Alyeska Investment Group, L.P. 6.5% 738,321 0.01% $5,087,032
Stonepine Capital Management, LLC 4% 460,359 2.5% $3,171,874
Bleichroeder LP 3.5% 400,000 0.48% $2,756,000
Velan Capital Investment Management LP 2.6% 300,000 1.2% $2,067,000
Point72 Asset Management, L.P. 1.8% 200,000 0% $1,378,000
Empery Asset Management, LP 1.5% 170,000 0% 1% $1,171,300
CORSAIR CAPITAL MANAGEMENT, L.P. 0.61% 70,000 0.08% $470,246
ROYAL BANK OF CANADA 0.48% 54,133 0% $373,000
Westside Investment Management, Inc. 0.27% 30,875 0.03% $212,734
BARCLAYS PLC 0.21% 23,999 -0% 0% $165,353
Rockefeller Capital Management L.P. 0.09% 10,700 0% 0% $73,723
Engineers Gate Manager LP 0.09% 10,388 0% $71,573
FNY Investment Advisers, LLC 0.07% 7,500 0.01% $51,000
RHUMBLINE ADVISERS 0.01% 1,565 +165% 0% $10,779
MORGAN STANLEY 0.01% 1,000 +400% 0% $6,890
GAMMA Investing LLC 0% 232 0% $1,598
Arax Advisory Partners 0% 200 0% 0% $1,378
UBS Group AG 0% 193 -95% 0% $1,330
OSAIC HOLDINGS, INC. 0% 10 0% 0% $68
Allworth Financial LP 0% 1 0% 0% $7
Dauntless Investment Group, LLC 0% 1 -100% 0% $7
CITIGROUP INC 0% 1 -100% 0% $7
MAI Capital Management 0% 0 -100% $0

Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,479,478 $17,070,899 +$14,797,378 $6.89 22
2025 Q3 158,075 $1,139,856 +$101,771 $7.21 11
2025 Q2 144,017 $902,466 +$902,466 $6.27 10